Loading page…
Nyxoah SA Sustainability Reports
Nyxoah SA is a medical technology company focused on the development and commercialization of innovative neurostimulation solutions to treat Obstructive Sleep Apnea (OSA). Its primary product platform is the Genio system, a patient-centered, bilateral hypoglossal nerve stimulation therapy.
Sector: Manufacturing
Country: Belgium
Exchange: Euronext Brussels
LEI: 5493002O1ESKZ18OXR80
FIGI: BBG006JRTF01
11 reports from 2020 to 2025